COVID-19 and Tocilizumab
Listen now
Description
Early studies of tocilizumab, a monoclonal antibody that binds interleukin-6 , were disappointing. However, the REMAP-CAP trial recently reported a benefit to tocilizumab in non-critically ill hospitalized patients with COVID-19. Now, from the RECOVERY trial (the trial that brought us dexamethasone), we have more good news for tocilizumab - which we cover in this podcast
Show notes: FOAMcast.org
Thanks for listening!
Lauren Westafer and Jeremy Faust
More Episodes
In this episode, we review a consensus guideline from the American College of Emergency Physicians on the use of topical anesthetics in corneal abrasions.
Show notes and references: FOAMcast.org
Thanks for listening!
Jeremy Faust and Lauren WEstafer
Published 02/16/24
Published 02/16/24
This episode covers emergency medicine-related recommendations from the American Heart Association's (AHA) clinical guideline on atrial fibrillation: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation Circulation. 2023
Show notes and references: FOAMcast.org
...
Published 12/13/23
Links
Twitter
Facebook
Instagram
Patreon
Genres
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
